ENVB logo

Enveric Biosciences (ENVB) Return On Equity

Annual ROE

-884.87%
-758.75%-601.61%

December 31, 2023


Summary


Performance

ENVB ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherENVBprofitabilitymetrics:

Quarterly ROE

-221.54%
+38.76%+14.89%

September 30, 2024


Summary


Performance

ENVB Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherENVBprofitabilitymetrics:

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

ENVB ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-601.6%+14.9%
3 y3 years-340.3%-151.2%
5 y5 years-690.9%-47.7%

ENVB ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-601.6%at low-151.2%+42.1%
5 y5-year-1588.0%at low-411.1%+42.1%
alltimeall time-202.7%at low-171.2%+89.5%

Enveric Biosciences ROE History

DateAnnualQuarterly
Sep 2024
-
-221.54%(-14.9%)
Jun 2024
-
-260.30%(-32.0%)
Mar 2024
-
-382.97%(+8.8%)
Dec 2023
-884.87%(+601.6%)
-351.98%(+26.3%)
Sep 2023
-
-278.69%(+65.4%)
Jun 2023
-
-168.47%(+57.7%)
Mar 2023
-
-106.86%(+21.2%)
Dec 2022
-126.12%(-42.6%)
-88.20%(-61.1%)
Sep 2022
-
-226.84%(+35.0%)
Jun 2022
-
-168.09%(+1.1%)
Mar 2022
-
-166.21%(-2.0%)
Dec 2021
-219.57%(+9.2%)
-169.64%(+264.0%)
Sep 2021
-
-46.60%(-30.4%)
Jun 2021
-
-66.96%(-10.0%)
Mar 2021
-
-74.42%(-2.2%)
Dec 2020
-200.98%(+283.4%)
-76.09%(+56.6%)
Sep 2020
-
-48.59%(+12.1%)
Jun 2020
-
-43.35%(-12.0%)
Mar 2020
-
-49.26%(-0.4%)
Dec 2019
-52.42%(-53.1%)
-49.46%(-67.0%)
Sep 2019
-
-150.02%(+41.8%)
Jun 2019
-
-105.83%(+10.2%)
Mar 2019
-
-96.02%(+11.1%)
Dec 2018
-111.88%(+91.8%)
-86.41%(-1021.2%)
Sep 2018
-
9.38%(-119.6%)
Jun 2018
-
-47.76%(-23.7%)
Mar 2018
-
-62.63%(-1.0%)
Dec 2017
-58.34%(+25.1%)
-63.26%(+6.6%)
Sep 2017
-
-59.34%(+25.2%)
Jun 2017
-
-47.41%(+29.2%)
Mar 2017
-
-36.70%(-51.0%)
Dec 2016
-46.65%(-92.7%)
-74.93%(-71.2%)
Sep 2016
-
-260.39%(-23.5%)
Jun 2016
-
-340.46%(-33.7%)
Mar 2016
-
-513.61%(+1304.5%)
Dec 2015
-639.34%(-174.2%)
-
Sep 2015
-
-36.57%(-187.1%)
Jun 2015
-
42.01%(-108.4%)
Mar 2015
-
-498.80%(-56.6%)
Dec 2014
861.54%(>+9900.0%)
-1149.17%(+431.5%)
Sep 2014
-
-216.22%(-201.9%)
Jun 2014
-
212.09%(+838.9%)
Mar 2014
-
22.59%(+2912.0%)
Dec 2013
0.99%(-99.2%)
0.75%(-99.2%)
Sep 2013
-
92.88%(-24.1%)
Jun 2013
-
122.44%(-31.2%)
Mar 2013
-
177.86%(-42.9%)
Dec 2012
122.39%(-116.9%)
311.39%(-121.7%)
Sep 2012
-
-1436.72%(+143.9%)
Jun 2012
-
-589.01%(-337.4%)
Mar 2012
-
248.11%(+92.2%)
Dec 2011
-726.09%(-1012.2%)
129.08%(+59.4%)
Sep 2011
-
80.96%(+25.9%)
Jun 2011
-
64.29%(-18.2%)
Mar 2011
-
78.64%(-29.2%)
Dec 2010
79.60%(-126.1%)
111.14%(-36.2%)
Sep 2010
-
174.22%(-42.1%)
Jun 2010
-
301.04%(-114.3%)
Mar 2010
-
-2104.75%(+524.8%)
DateAnnualQuarterly
Dec 2009
-304.96%(+1604.6%)
-336.87%(+62.4%)
Sep 2009
-
-207.43%(+39.7%)
Jun 2009
-
-148.46%(+412.5%)
Mar 2009
-
-28.97%(+32.0%)
Dec 2008
-17.89%(-121.4%)
-21.94%(+34.9%)
Sep 2008
-
-16.26%(-156.6%)
Jun 2008
-
28.73%(-30.7%)
Mar 2008
-
41.47%(-48.4%)
Dec 2007
83.50%(-229.5%)
80.36%(-22.0%)
Sep 2007
-
103.02%(+113.5%)
Jun 2007
-
48.25%(+337.0%)
Mar 2007
-
11.04%(-115.9%)
Dec 2006
-64.47%(+499.2%)
-69.59%(-11.9%)
Sep 2006
-
-78.95%(+43.8%)
Jun 2006
-
-54.92%(+59.1%)
Mar 2006
-
-34.53%(+246.3%)
Dec 2005
-10.76%(-40.1%)
-9.97%(-129.1%)
Sep 2005
-
34.28%(+66.1%)
Jun 2005
-
20.64%(-757.3%)
Mar 2005
-
-3.14%(-84.4%)
Dec 2004
-17.97%(-56.8%)
-20.08%(-61.1%)
Sep 2004
-
-51.66%(+6.0%)
Jun 2004
-
-48.75%(-4.8%)
Mar 2004
-
-51.22%(+22.3%)
Dec 2003
-41.56%(-3321.7%)
-41.88%(+30.7%)
Sep 2003
-
-32.04%(+49.0%)
Jun 2003
-
-21.51%(+294.7%)
Mar 2003
-
-5.45%(-525.8%)
Dec 2002
1.29%(-108.2%)
1.28%(-70.9%)
Sep 2002
-
4.40%(-151.3%)
Jun 2002
-
-8.57%(-43.1%)
Mar 2002
-
-15.07%(-3.8%)
Dec 2001
-15.68%(-149.6%)
-15.67%(-9.2%)
Sep 2001
-
-17.26%(-3772.3%)
Jun 2001
-
0.47%(-96.6%)
Mar 2001
-
13.98%(-66.7%)
Dec 2000
31.59%(-31.6%)
41.95%(-114.6%)
Sep 2000
-
-288.02%(-24.8%)
Jun 2000
-
-382.90%(-38.2%)
Mar 2000
-
-619.84%(-15.0%)
Dec 1999
46.19%(-87.6%)
-
Dec 1998
372.84%(-289.3%)
-729.18%(+134.9%)
Sep 1998
-
-310.39%(+36.3%)
Jun 1998
-
-227.70%(+17.6%)
Mar 1998
-
-193.70%(+19.0%)
Dec 1997
-196.95%(-73.0%)
-162.83%(-76.8%)
Sep 1997
-
-702.85%(+16.3%)
Jun 1997
-
-604.18%(-2.3%)
Mar 1997
-
-618.63%(-1.6%)
Dec 1996
-728.92%(+480.9%)
-628.96%(+353.4%)
Sep 1996
-
-138.73%(-2.1%)
Jun 1996
-
-141.73%(+1.6%)
Mar 1996
-
-139.44%(+66.4%)
Dec 1995
-125.49%(-11.1%)
-83.78%(-89.5%)
Jun 1995
-
-800.00%(+9.1%)
Mar 1995
-
-733.33%(+10.0%)
Dec 1994
-141.18%(-76.5%)
-
Nov 1994
-
-666.67%(+11.1%)
Aug 1994
-
-600.00%
Aug 1994
-600.00%
-

FAQ

  • What is Enveric Biosciences annual return on equity?
  • What is the all time high annual ROE for Enveric Biosciences?
  • What is Enveric Biosciences annual ROE year-on-year change?
  • What is Enveric Biosciences quarterly return on equity?
  • What is the all time high quarterly ROE for Enveric Biosciences?
  • What is Enveric Biosciences quarterly ROE year-on-year change?

What is Enveric Biosciences annual return on equity?

The current annual ROE of ENVB is -884.87%

What is the all time high annual ROE for Enveric Biosciences?

Enveric Biosciences all-time high annual return on equity is 861.54%

What is Enveric Biosciences annual ROE year-on-year change?

Over the past year, ENVB annual return on equity has changed by -758.75% (-601.61%)

What is Enveric Biosciences quarterly return on equity?

The current quarterly ROE of ENVB is -221.54%

What is the all time high quarterly ROE for Enveric Biosciences?

Enveric Biosciences all-time high quarterly return on equity is 311.39%

What is Enveric Biosciences quarterly ROE year-on-year change?

Over the past year, ENVB quarterly return on equity has changed by +38.76% (+14.89%)